Vol. 11 (06) pp. 727-729 DOI: 10.21474/IJAR01/17120

REMDESIVIR INDUCED SINUS BRADYCARDIA IN A 53-YEAR-OLD WOMAN DURING THE TREATMENT OF COVID-19 INFECTION: A CASE REPORT

, and
  • Medical Officer, Department of Internal Medicine and Intensive Care Unit (ICU), HAMS Hospital, Kathmandu.
  • Medical Officer, Department of Internal Medicine and Intensive Care Unit (ICU),Everest Hospital, Kathmandu.
  • Medical Officer, Department of Internal Medicine and Intensive Care Unit (ICU), Institute of Medicine, Kathmandu.
37 Downloads 129 Views
Crossref

Download Full Paper (PDF)

Abstract

We report a case of a 53-year-old woman with severe COVID-19 infection. On the second day of her treatment with Remdesivir and other standard therapies, sinus bradycardia was noted, requiring atropine and dopamine. Workup excluded the secondary causes. A probable diagnosis of Remdesivir-induced bradycardia was made and thus, Remdesivir was discontinued. Her condition normalized after four days of discontinuing Remdesivir. Hence, the treating physicians must be aware of the cardiac adverse effects of Remdesivir.

Keywords

Article Analytics

How to Cite This Article

Roshan Bhandari, Richa Paudyal and Ghanashyam Pandey (2023); REMDESIVIR INDUCED SINUS BRADYCARDIA IN A 53-YEAR-OLD WOMAN DURING THE TREATMENT OF COVID-19 INFECTION: A CASE REPORT, Int. J. of Adv. Res., 11 (06), 727-729, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/17120

Corresponding Author

Dr. Roshan Bhandari
Medical Officer, Department of Internal Medicine and Intensive Care Unit (ICU), HAMS Hospital, Kathmandu, Nepal
Nepal
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.